ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE.
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury; D003523:Cycloserine; D004342:Drug Hypersensitivity; D005000:Ethionamide; D005602:France; D006505:Hepatitis; D007538:Isoniazid / Q000633:toxicity*; D007564:Japan; D007612:Kanamycin; D008111:Liver Function Tests; D010118:Oxytetracycline; D010336:Pathology; D011241:Prednisone / Q000009:adverse effects*; D013307:Streptomycin / Q000009:adverse effects*; D013444:Sulfisoxazole; D014116:Toxicology; D014376:Tuberculosis
D000636:Aminosalicylic Acids; D007612:Kanamycin; D010131:Aminosalicylic Acid; D013444:Sulfisoxazole; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D011241:Prednisone; D010118:Oxytetracycline; D013307:Streptomycin
AMINOSALICYLIC ACID; BIOPSY; CYCLOSERINE; DRUG HYPERSENSITIVITY; ETHIONIAMIDE; FRANCE; HEPATITIS, TOXIC; ISONIAZID TOXICOLOGY; JAPAN; KANAMYCIN; LIVER FUNCTION TESTS; OXYTETRACYCLINE; PATHOLOGY; PREDNISONE TOXICOLOGY; STREPTOMYCIN TOXICOLOGY; SULFISOXAZOLE; TOXICOLOGIC REPORT; TUBERCULOSIS